Compare RNST & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RNST | INSP |
|---|---|---|
| Founded | 1904 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.8B |
| IPO Year | N/A | 2018 |
| Metric | RNST | INSP |
|---|---|---|
| Price | $36.34 | $138.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 15 |
| Target Price | $43.17 | ★ $127.07 |
| AVG Volume (30 Days) | 484.8K | ★ 1.5M |
| Earning Date | 10-28-2025 | 11-03-2025 |
| Dividend Yield | ★ 2.53% | N/A |
| EPS Growth | N/A | ★ 34.77 |
| EPS | ★ 1.84 | 1.48 |
| Revenue | $775,309,000.00 | ★ $882,622,000.00 |
| Revenue This Year | $43.37 | $14.97 |
| Revenue Next Year | $13.13 | $11.81 |
| P/E Ratio | ★ $19.79 | $92.68 |
| Revenue Growth | 13.04 | ★ 16.81 |
| 52 Week Low | $26.97 | $70.77 |
| 52 Week High | $40.40 | $216.01 |
| Indicator | RNST | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 62.21 | 76.95 |
| Support Level | $35.16 | $132.39 |
| Resistance Level | $36.18 | $142.56 |
| Average True Range (ATR) | 0.80 | 7.26 |
| MACD | 0.25 | 3.75 |
| Stochastic Oscillator | 96.11 | 90.18 |
Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.